Capricor Therapeutics, Inc.

US$9.00As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CAPRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (11.05%)
Div yield —
ROE (73.70%)
Biotechnology
Beta (5Y) 0.77
PE TTM —
TSR TTM 38.25%
Mkt cap US$523.3M
ROIC (38.11%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
16.92%
39.29%
Hold 11|8|12|8|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.10
0.10
0.11
0.12
0.32%
2.53%
12.68%
22.62%
Revenue$M
30.47
30.83
32.34
31.62
5.64%
4.23%
8.55%
0.80%
Peers (US$523.3M)
Cap (US$)
PE
506.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.088
0.815
0.686
EBIT/Intx
0.827
1.100
0.906
Own earn%
(402.06)
48.26
45.08
Sh yield%
31.48
36.95
33.77
Owners
Insiders/Inst%
1.36
39.73
Short interest%
2.84
SBC / revenue%
2.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
0–5
$1 testx
−0.1
Incr. ROIC%
1